- Human Biospecimens
- For Researchers
- For Biospecimen Contributors
- For Patients
November 18, 2014
When it comes to gastrointestinal disorders, a growing number of researchers are realizing there is one variable that may deserve more attention: the gut microbiome.
For years, researchers conducting experiments to evaluate potential new drugs did so through randomized controlled trials, but personalized medicine is driving alternative development tracks.
November 16, 2014
During the past few years, the federal government has been pushing for U.S. practitioners and hospitals to adopt electronic health record (EHR) systems. However, the full potential of EHRs cannot be realized until they are adopted more universally and the systems used by various providers are able to easily communicate with each other.
As gene sequencing technologies became increasingly advanced, scientists are finding new gene fusions and mutations that lead to more targeted therapies. Specifically, scientists have recently found that some “pan-negative” melanomas are responsive to existing medications.
November 13, 2014
Advances in technology are making it possible for scientists to study proteomics more closely and in tandem with genomics, which will greatly improve doctors’ and researchers’ understanding of how diseases develop and how they can be treated.
November 7, 2014
Healthcare providers, scientists and biopharmaceutical companies are all realizing that personalized medicine is the next step in the evolution of patient care. Not only can it treat individuals’ illnesses more effectively, but it can do so while minimizing the likelihood of side effects. These dynamics will improve patient outcomes while curbing healthcare expenses.
November 4, 2014
There are a number of diseases that are uniquely prevalent among distinct population groups and in particular, researchers are studying the genome of the Ashkenazi Jews due to their increased likelihood of developing genetic disorders.